<DOC>
	<DOC>NCT02397525</DOC>
	<brief_summary>Evaluate the safety of three 8-week courses of treatment with LIPO-202 in non-obese patients who have central abdominal bulging. Efficacy measurements will also be collected.</brief_summary>
	<brief_title>An Open-Label Study to Evaluate Retreatment With LIPO-202</brief_title>
	<detailed_description />
	<criteria>Provided consent Healthy male or nonpregnant female subjects BMI &lt; 30 kg/m2 Stable diet and exercise routine Central abdominal bulging that is at least "Slight Bulge, Not Flat" Have had any treatment of the fat around your abdomen, including surgical procedures (tummy tuck, liposuction), injections for fat loss or treatments with devices to reduce fat in your abdomen Plan on starting a weight loss or exercise program during the study. Be a woman who is pregnant, breast feeding, have had a baby within 6 months and/or not using appropriate birth control. Known hypersensitivity to study drugs Prior or current enrollment in any Neothetics (formerly Lithera) study involving LIPO102 or LIPO202</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>